Literature DB >> 11124462

Alteration of 6-phosphofructo-1-kinase subunits during neonatal maturation of the rat cochlear cells.

G Armour1, Y Mhaskar, L Rybak, G Dunaway.   

Abstract

During postnatal development of rat cochlear cells and the onset of hearing (10-23 days), the increasing endocochlear potential and energy requirements are largely provided by increased glucose utilization. It is well established that the ability of maturing rat tissues to use glucose is directly related to alteration of 6-phosphofructo-1-kinase (PFK) subunits. To gain insight into the alteration of PFK subunit levels in the cochlea from 6 to 60 days of age, PFK subunit types were measured in sections of paraffin-embedded temporal bone using IgG specific for each type of PFK subunit and quantified by computer image analysis. Although the L-type and C-type subunits did not exhibit statistically significant changes in the cochlear structures during maturation, the levels of M-type subunit in the stria vascularis cells, spiral ligament cell types I, II, and III, outer hair cells, inner hair cells, and support cells significantly increased. Also, the type IV and V spiral ligament fibrocytes during this period did not exhibit significant alterations of the M-type subunit. These data suggest that during neonatal development of the cochlear, the elevated levels of the M-type subunit are associated with increased glucose utilization and the onset of hearing.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11124462     DOI: 10.1016/s0378-5955(00)00222-7

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  2 in total

1.  Identification and quantification of full-length BK channel variants in the developing mouse cochlea.

Authors:  Yoshihisa Sakai; Margaret Harvey; Bernd Sokolowski
Journal:  J Neurosci Res       Date:  2011-07-28       Impact factor: 4.164

2.  Metabolic disorders prevalence in sudden deafness.

Authors:  Jeanne Oiticica; Roseli Saraiva Moreira Bittar
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.